Oncology Molecular Diagnostics Market Report by Cancer Type (Breast Cancer, Prostate Cancer, Colorectal Cancer, Cervical Cancer, Liver Cancer, Lung Cancer, Blood Cancer, and Others), Product (Instruments, Reagents, and Others), Technology (Polymerase Chain Reaction (PCR), In Situ Hybridization, Chips and Microarrays, Isothermal Nucleic Acid Amplification Technology (INAAT), Mass Spectrometry, DNA and NGS Sequencing, Transcription Mediated Amplification (TMA), and Others), End-User (Hospitals and Clinics, Reference Laboratories, and Others), and Region 2025-2033

Oncology Molecular Diagnostics Market Report by Cancer Type (Breast Cancer, Prostate Cancer, Colorectal Cancer, Cervical Cancer, Liver Cancer, Lung Cancer, Blood Cancer, and Others), Product (Instruments, Reagents, and Others), Technology (Polymerase Chain Reaction (PCR), In Situ Hybridization, Chips and Microarrays, Isothermal Nucleic Acid Amplification Technology (INAAT), Mass Spectrometry, DNA and NGS Sequencing, Transcription Mediated Amplification (TMA), and Others), End-User (Hospitals and Clinics, Reference Laboratories, and Others), and Region 2025-2033

Report Format: PDF+Excel | Report ID: SR112025A2396

1   Preface
2   Scope and Methodology 

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction

    4.1    Overview
    4.2    Key Industry Trends
5   Global Oncology Molecular Diagnostics Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6   Market Breakup by Cancer Type
    6.1    Breast Cancer
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Prostate Cancer
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    Colorectal Cancer
        6.3.1 Market Trends
        6.3.2 Market Forecast
    6.4    Cervical Cancer
        6.4.1 Market Trends
        6.4.2 Market Forecast
    6.5    Liver Cancer
        6.5.1 Market Trends
        6.5.2 Market Forecast
    6.6    Lung Cancer
        6.6.1 Market Trends
        6.6.2 Market Forecast
    6.7    Blood Cancer
        6.7.1 Market Trends
        6.7.2 Market Forecast
    6.8    Others
        6.8.1 Market Trends
        6.8.2 Market Forecast
7   Market Breakup by Product
    7.1    Instruments
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Reagents
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Others
        7.3.1 Market Trends
        7.3.2 Market Forecast
8   Market Breakup by Technology
    8.1    Polymerase Chain Reaction (PCR)
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    In Situ Hybridization
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Chips and Microarrays
        8.3.1 Market Trends
        8.3.2 Market Forecast
    8.4    Isothermal Nucleic Acid Amplification Technology (INAAT)
        8.4.1 Market Trends
        8.4.2 Market Forecast
    8.5    Mass Spectrometry
        8.5.1 Market Trends
        8.5.2 Market Forecast
    8.6    DNA and NGS Sequencing
        8.6.1 Market Trends
        8.6.2 Market Forecast
    8.7    Transcription Mediated Amplification (TMA)
        8.7.1 Market Trends
        8.7.2 Market Forecast
    8.8    Others
        8.8.1 Market Trends
        8.8.2 Market Forecast
9   Market Breakup by End-User
    9.1    Hospitals and Clinics
        9.1.1 Market Trends
        9.1.2 Market Forecast
    9.2    Reference Laboratories
        9.2.1 Market Trends
        9.2.2 Market Forecast 
    9.3    Others
        9.3.1 Market Trends
        9.3.2 Market Forecast
10  Market Breakup by Region
    10.1    North America
        10.1.1 United States
           10.1.1.1 Market Trends
           10.1.1.2 Market Forecast
        10.1.2 Canada
           10.1.2.1 Market Trends
           10.1.2.2 Market Forecast
    10.2    Asia Pacific
        10.2.1 China
           10.2.1.1 Market Trends
           10.2.1.2 Market Forecast
        10.2.2 Japan
           10.2.2.1 Market Trends
           10.2.2.2 Market Forecast
        10.2.3 India
           10.2.3.1 Market Trends
           10.2.3.2 Market Forecast
        10.2.4 South Korea
           10.2.4.1 Market Trends
           10.2.4.2 Market Forecast
        10.2.5 Australia
           10.2.5.1 Market Trends
           10.2.5.2 Market Forecast
        10.2.6 Indonesia
           10.2.6.1 Market Trends
           10.2.6.2 Market Forecast
        10.2.7 Others
           10.2.7.1 Market Trends
           10.2.7.2 Market Forecast
    10.3    Europe
        10.3.1 Germany
           10.3.1.1 Market Trends
           10.3.1.2 Market Forecast
        10.3.2 France
           10.3.2.1 Market Trends
           10.3.2.2 Market Forecast
        10.3.3 United Kingdom
           10.3.3.1 Market Trends
           10.3.3.2 Market Forecast
        10.3.4 Italy
           10.3.4.1 Market Trends
           10.3.4.2 Market Forecast
        10.3.5 Spain
           10.3.5.1 Market Trends
           10.3.5.2 Market Forecast
        10.3.6 Russia
           10.3.6.1 Market Trends
           10.3.6.2 Market Forecast
        10.3.7 Others
           10.3.7.1 Market Trends
           10.3.7.2 Market Forecast
    10.4    Latin America
        10.4.1 Brazil
           10.4.1.1 Market Trends
           10.4.1.2 Market Forecast
        10.4.2 Mexico
           10.4.2.1 Market Trends
           10.4.2.2 Market Forecast
        10.4.3 Others
           10.4.3.1 Market Trends
           10.4.3.2 Market Forecast
    10.5    Middle East and Africa
        10.5.1 Market Trends
        10.5.2 Market Breakup by Country
        10.5.3 Market Forecast
11  SWOT Analysis
    11.1    Overview
    11.2    Strengths
    11.3    Weaknesses
    11.4    Opportunities
    11.5    Threats
12  Value Chain Analysis
13  Porters Five Forces Analysis

    13.1    Overview
    13.2    Bargaining Power of Buyers
    13.3    Bargaining Power of Suppliers
    13.4    Degree of Competition
    13.5    Threat of New Entrants
    13.6    Threat of Substitutes
14  Price Analysis
15  Competitive Landscape

    15.1    Market Structure
    15.2    Key Players
    15.3    Profiles of Key Players
        15.3.1    Agilent Technologies, Inc.
           15.3.1.1 Company Overview
           15.3.1.2 Product Portfolio 
           15.3.1.3 Financials
           15.3.1.4 SWOT Analysis
        15.3.2    Abbott Laboratories
           15.3.2.1 Company Overview
           15.3.2.2 Product Portfolio 
           15.3.2.3 Financials
           15.3.2.4 SWOT Analysis
        15.3.3    Bayer AG
           15.3.3.1 Company Overview
           15.3.3.2 Product Portfolio 
           15.3.3.3 Financials
           15.3.3.4 SWOT Analysis
        15.3.4    Becton, Dickinson and Company
           15.3.4.1 Company Overview
           15.3.4.2 Product Portfolio 
           15.3.4.3 Financials
           15.3.4.4 SWOT Analysis
        15.3.5    Danaher Corporation
           15.3.5.1 Company Overview
           15.3.5.2 Product Portfolio 
           15.3.5.3 SWOT Analysis
        15.3.6    F. Hoffmann-La Roche AG
           15.3.6.1 Company Overview
           15.3.6.2 Product Portfolio 
           15.3.6.3 SWOT Analysis
        15.3.7    Hologic, Inc.
           15.3.7.1 Company Overview
           15.3.7.2 Product Portfolio 
           15.3.7.3 Financials
           15.3.7.4 SWOT Analysis
        15.3.8    Qiagen N.V.
           15.3.8.1 Company Overview
           15.3.8.2 Product Portfolio 
           15.3.8.3 Financials
           15.3.8.4 SWOT Analysis
        15.3.9    Siemens Healthcare
           15.3.9.1 Company Overview
           15.3.9.2 Product Portfolio 
           15.3.9.3 Financials
           15.3.9.4 SWOT Analysis
        15.3.10    Sysmex Corporation
           15.3.10.1 Company Overview
           15.3.10.2 Product Portfolio 
           15.3.10.3 Financials
           15.3.10.4 SWOT Analysis

List of Figures

Figure 1: Global: Oncology Molecular Diagnostics Market: Major Drivers and Challenges
Figure 2: Global: Oncology Molecular Diagnostics Market: Sales Value (in Billion USD), 2019-2024
Figure 3: Global: Oncology Molecular Diagnostics Market: Breakup by Cancer Type (in %), 2024
Figure 4: Global: Oncology Molecular Diagnostics Market: Breakup by Product (in %), 2024
Figure 5: Global: Oncology Molecular Diagnostics Market: Breakup by Technology (in %), 2024 
Figure 6: Global: Oncology Molecular Diagnostics Market: Breakup by End-User (in %), 2024
Figure 7: Global: Oncology Molecular Diagnostics Market: Breakup by Region (in %), 2024
Figure 8: Global: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 9: Global: Oncology Molecular Diagnostics (Breast Cancer) Market: Sales Value (in Million USD), 2019 & 2024
Figure 10: Global: Oncology Molecular Diagnostics (Breast Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 11: Global: Oncology Molecular Diagnostics (Prostate Cancer) Market: Sales Value (in Million USD), 2019 & 2024
Figure 12: Global: Oncology Molecular Diagnostics (Prostate Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 13: Global: Oncology Molecular Diagnostics (Colorectal Cancer) Market: Sales Value (in Million USD), 2019 & 2024
Figure 14: Global: Oncology Molecular Diagnostics (Colorectal Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 15: Global: Oncology Molecular Diagnostics (Cervical Cancer) Market: Sales Value (in Million USD), 2019 & 2024
Figure 16: Global: Oncology Molecular Diagnostics (Cervical Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 17: Global: Oncology Molecular Diagnostics (Liver Cancer) Market: Sales Value (in Million USD), 2019 & 2024
Figure 18: Global: Oncology Molecular Diagnostics (Liver Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 19: Global: Oncology Molecular Diagnostics (Lung Cancer) Market: Sales Value (in Million USD), 2019 & 2024
Figure 20: Global: Oncology Molecular Diagnostics (Lung Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 21: Global: Oncology Molecular Diagnostics (Blood Cancer) Market: Sales Value (in Million USD), 2019 & 2024
Figure 22: Global: Oncology Molecular Diagnostics (Blood Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 23: Global: Oncology Molecular Diagnostics (Other Cancer Types) Market: Sales Value (in Million USD), 2019 & 2024
Figure 24: Global: Oncology Molecular Diagnostics (Other Cancer Types) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 25: Global: Oncology Molecular Diagnostics (Instruments) Market: Sales Value (in Million USD), 2019 & 2024
Figure 26: Global: Oncology Molecular Diagnostics (Instruments) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 27: Global: Oncology Molecular Diagnostics (Reagents) Market: Sales Value (in Million USD), 2019 & 2024
Figure 28: Global: Oncology Molecular Diagnostics (Reagents) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 29: Global: Oncology Molecular Diagnostics (Other Products) Market: Sales Value (in Million USD), 2019 & 2024
Figure 30: Global: Oncology Molecular Diagnostics (Other Products) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 31: Global: Oncology Molecular Diagnostics (Polymerase Chain Reaction-PCR) Market: Sales Value (in Million USD), 2019 & 2024
Figure 32: Global: Oncology Molecular Diagnostics (Polymerase Chain Reaction-PCR) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 33: Global: Oncology Molecular Diagnostics (In Situ Hybridization) Market: Sales Value (in Million USD), 2019 & 2024
Figure 34: Global: Oncology Molecular Diagnostics (In Situ Hybridization) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 35: Global: Oncology Molecular Diagnostics (Chips and Microarrays) Market: Sales Value (in Million USD), 2019 & 2024
Figure 36: Global: Oncology Molecular Diagnostics (Chips and Microarrays) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 37: Global: Oncology Molecular Diagnostics (Isothermal Nucleic Acid Amplification Technology-INAAT) Market: Sales Value (in Million USD), 2019 & 2024
Figure 38: Global: Oncology Molecular Diagnostics (Isothermal Nucleic Acid Amplification Technology-INAAT) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 39: Global: Oncology Molecular Diagnostics (Mass Spectrometry) Market: Sales Value (in Million USD), 2019 & 2024
Figure 40: Global: Oncology Molecular Diagnostics (Mass Spectrometry) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 41: Global: Oncology Molecular Diagnostics (DNA and NGS Sequencing) Market: Sales Value (in Million USD), 2019 & 2024
Figure 42: Global: Oncology Molecular Diagnostics (DNA and NGS Sequencing) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 43: Global: Oncology Molecular Diagnostics (Transcription Mediated Amplification-TMA) Market: Sales Value (in Million USD), 2019 & 2024
Figure 44: Global: Oncology Molecular Diagnostics (Transcription Mediated Amplification-TMA) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 45: Global: Oncology Molecular Diagnostics (Other Technologies) Market: Sales Value (in Million USD), 2019 & 2024
Figure 46: Global: Oncology Molecular Diagnostics (Other Technologies) Market Forecast: Sales Value (in Million USD), 2025-2033 
Figure 47: Global: Oncology Molecular Diagnostics (Hospitals and Clinics) Market: Sales Value (in Million USD), 2019 & 2024
Figure 48: Global: Oncology Molecular Diagnostics (Hospitals and Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 49: Global: Oncology Molecular Diagnostics (Reference Laboratories) Market: Sales Value (in Million USD), 2019 & 2024
Figure 50: Global: Oncology Molecular Diagnostics (Reference Laboratories) Market Forecast: Sales Value (in Million USD), 2025-2033 
Figure 51: Global: Oncology Molecular Diagnostics (Other End-Users) Market: Sales Value (in Million USD), 2019 & 2024
Figure 52: Global: Oncology Molecular Diagnostics (Other End-Users) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 53: North America: Oncology Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 54: North America: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 55: United States: Oncology Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 56: United States: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 57: Canada: Oncology Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 58: Canada: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 59: Asia Pacific: Oncology Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 60: Asia Pacific: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 61: China: Oncology Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 62: China: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 63: Japan: Oncology Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 64: Japan: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 65: India: Oncology Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 66: India: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 67: South Korea: Oncology Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 68: South Korea: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 69: Australia: Oncology Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 70: Australia: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 71: Indonesia: Oncology Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 72: Indonesia: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 73: Others: Oncology Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 74: Others: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 75: Europe: Oncology Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 76: Europe: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 77: Germany: Oncology Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 78: Germany: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 79: France: Oncology Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 80: France: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 81: United Kingdom: Oncology Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 82: United Kingdom: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 83: Italy: Oncology Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 84: Italy: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 85: Spain: Oncology Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 86: Spain: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 87: Russia: Oncology Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 88: Russia: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 89: Others: Oncology Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 90: Others: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 91: Latin America: Oncology Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 92: Latin America: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 93: Brazil: Oncology Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 94: Brazil: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 95: Mexico: Oncology Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 96: Mexico: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 97: Others: Oncology Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 98: Others: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 99: Middle East and Africa: Oncology Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 100: Middle East and Africa: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 101: Global: Oncology Molecular Diagnostics Industry: SWOT Analysis
Figure 102: Global: Oncology Molecular Diagnostics Industry: Value Chain Analysis
Figure 103: Global: Oncology Molecular Diagnostics Industry: Porter’s Five Forces Analysis

List of Tables

Table 1: Global: Oncology Molecular Diagnostics Market: Key Industry Highlights, 2024 and 2033
Table 2: Global: Oncology Molecular Diagnostics Market Forecast: Breakup by Cancer Type (in Million USD), 2025-2033
Table 3: Global: Oncology Molecular Diagnostics Market Forecast: Breakup by Product (in Million USD), 2025-2033
Table 4: Global: Oncology Molecular Diagnostics Market Forecast: Breakup by Technology (in Million USD), 2025-2033 
Table 5: Global: Oncology Molecular Diagnostics Market Forecast: Breakup by End-User (in Million USD), 2025-2033
Table 6: Global: Oncology Molecular Diagnostics Market Forecast: Breakup by Region (in Million USD), 2025-2033
Table 7: Global: Oncology Molecular Diagnostics Market Structure
Table 8: Global: Oncology Molecular Diagnostics Market: Key Players

Oncology Molecular Diagnostics Market Report by Cancer Type (Breast Cancer, Prostate Cancer, Colorectal Cancer, Cervical Cancer, Liver Cancer, Lung Cancer, Blood Cancer, and Others), Product (Instruments, Reagents, and Others), Technology (Polymerase Chain Reaction (PCR), In Situ Hybridization, Chips and Microarrays, Isothermal Nucleic Acid Amplification Technology (INAAT), Mass Spectrometry, DNA and NGS Sequencing, Transcription Mediated Amplification (TMA), and Others), End-User (Hospitals and Clinics, Reference Laboratories, and Others), and Region 2025-2033
Purchase Options New Year Sale
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials